Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Tobi

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Life (Basel, Switzerland)|March 27, 2025
New World Primates and Their Human Counterparts Share Diseases That Abound with CEACAM and Other Effector MoleculesMartin Tobi, Daniel Ezekwudo, Benita McVicker, et al.
Digestive Diseases and Sciences|March 21, 2003
Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomasRafiq A Sheikh, Byung Hee Min, Shagufta Yasmeen, et al.
Journal of Clinical Gastroenterology|June 20, 2007
Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational studyNolan E Perez, Firdous A Siddiqui, Milton G Mutchnick, et al.
World Journal of Gastroenterology|August 6, 2008
Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trialRichard Jaszewski, Sabeena Misra, Martin Tobi, et al.
Biomolecules|July 29, 2025
Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine ProfilesMartin Tobi, Diptaraj Chaudhari, Elizabeth P Ryan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injuryEdgar Ben-Josef, Sue Han, Martin Tobi, et al.
Digestive Diseases and Sciences|October 16, 2007
An anti-adenoma antibody, Adnab-9, may reflect the risk for neoplastic progression in familial hamartomatous polyposis syndromesMartin Tobi, Michael Kam, Nadeem Ullah, et al.
Cancer Detection and Prevention|August 2, 2003
Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomasKiran K Nagothu, Richard Jaszewski, Lathika Moragoda, et al.
Biomolecules|September 28, 2024
Predicting Regression of Barrett's Esophagus-Can All the King's Men Put It Together Again?Martin Tobi, Nabiha Khoury, Omar Al-Subee, et al.
International Journal of Molecular Sciences|December 23, 2023
The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9Martin Tobi, Fadi Antaki, Mary Ann Rambus, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Life (Basel, Switzerland)|March 27, 2025
New World Primates and Their Human Counterparts Share Diseases That Abound with CEACAM and Other Effector MoleculesMartin Tobi, Daniel Ezekwudo, Benita McVicker, et al.
Digestive Diseases and Sciences|March 21, 2003
Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomasRafiq A Sheikh, Byung Hee Min, Shagufta Yasmeen, et al.
Journal of Clinical Gastroenterology|June 20, 2007
Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational studyNolan E Perez, Firdous A Siddiqui, Milton G Mutchnick, et al.
World Journal of Gastroenterology|August 6, 2008
Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trialRichard Jaszewski, Sabeena Misra, Martin Tobi, et al.
Biomolecules|July 29, 2025
Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine ProfilesMartin Tobi, Diptaraj Chaudhari, Elizabeth P Ryan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injuryEdgar Ben-Josef, Sue Han, Martin Tobi, et al.
Digestive Diseases and Sciences|October 16, 2007
An anti-adenoma antibody, Adnab-9, may reflect the risk for neoplastic progression in familial hamartomatous polyposis syndromesMartin Tobi, Michael Kam, Nadeem Ullah, et al.
Cancer Detection and Prevention|August 2, 2003
Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomasKiran K Nagothu, Richard Jaszewski, Lathika Moragoda, et al.
Biomolecules|September 28, 2024
Predicting Regression of Barrett's Esophagus-Can All the King's Men Put It Together Again?Martin Tobi, Nabiha Khoury, Omar Al-Subee, et al.
International Journal of Molecular Sciences|December 23, 2023
The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9Martin Tobi, Fadi Antaki, Mary Ann Rambus, et al.
Pageof 6